U.S. Point-of-care Glucose Testing Market Size & Outlook

The point-of-care glucose testing market in the United States is expected to reach a projected revenue of US$ 1,556.7 million by 2030. A compound annual growth rate of 4.4% is expected of the United States point-of-care glucose testing market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,148.9
Forecast, 2030 (US$M)
$1,556.7
CAGR, 2024 - 2030
4.4%
Report Coverage
U.S.

U.S. point-of-care glucose testing market, 2018-2030 (US$M)

U.S.

U.S. point-of-care glucose testing market highlights

  • The U.S. point-of-care glucose testing market generated a revenue of USD 1,148.9 million in 2023 and is expected to reach USD 1,556.7 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 4.4% from 2024 to 2030.
  • In terms of segment, accu-chek inform ii was the largest revenue generating product in 2023.
  • Freestyle Lite is the most lucrative product segment registering the fastest growth during the forecast period.


Point-of-care glucose testing market data book summary

Market revenue in 2023USD 1,148.9 million
Market revenue in 2030USD 1,556.7 million
Growth rate4.4% (CAGR from 2023 to 2030)
Largest segmentAccu-chek inform ii
Fastest growing segmentFreestyle Lite
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAccu Check Aviva Meter, Onetouch Verio Flex, I-STAT, Freestyle Lite, Bayer CONTOUR blood glucose monitoring system, True Metrix, Accu-Chek Inform II, StatStrip
Key market players worldwideRoche, Abbott Laboratories, Nipro Corp, Nova Biomedical, ACON Laboratories, Bayer AG, EKF Diagnostics Holdings PLC


Other key industry trends

  • In terms of revenue, U.S. accounted for 33.8% of the global point-of-care glucose testing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. point-of-care glucose testing market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 1,556.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Point-of-Care Glucose Testing Market Companies

Name Profile # Employees HQ Website

U.S. point-of-care glucose testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care glucose testing market will help companies and investors design strategic landscapes.


Accu-chek inform ii was the largest segment with a revenue share of 17.97% in 2023. Horizon Databook has segmented the U.S. point-of-care glucose testing market based on accu check aviva meter, onetouch verio flex, i-stat, freestyle lite, bayer contour blood glucose monitoring system, true metrix, accu-chek inform ii, statstrip covering the revenue growth of each sub-segment from 2018 to 2030.


Large population at high risk of diabetes in the U.S. is a key factor contributing to the dominance of the U.S. in North America POC glucose testing market in 2020. Diabetes was reported to be 7th most common cause of death in the U.S. with more than 30.9 million Americans suffering from the disease in 2019.

Presence of government organizations focusing on creating awareness regarding diabetes and glucose testing products available in the market has propelled the market growth in the country. For instance, American Heart Association, American Diabetes Association, and Pan American Health Organization are especially involved in such initiatives.

According to International Diabetes Federation, the prevalence rate of diabetes is 13.3% of the total population. Moreover, rising healthcare expenditure on diabetes and increasing cost per person on diabetes are boosting the demand.

Reasons to subscribe to U.S. point-of-care glucose testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. point-of-care glucose testing market databook

  • Our clientele includes a mix of point-of-care glucose testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. point-of-care glucose testing market size, by product, 2018-2030 (US$M)

U.S. Point-of-Care Glucose Testing Market Outlook Share, 2023 & 2030 (US$M)

U.S. point-of-care glucose testing market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more